|
|
|
|
|
|
|
 DUSPATAL® (mebeverine) is one of Solvay Pharmaceuticals' major products for Irritable Bowel Syndrome (IBS). IBS affects at least 10% of the population. Duspatal® belongs to the group of medicines known as antispasmodics. It relieves spasms and avoids atony in the intestine. Mebeverine is available in tablet form. As a continuous improvement of the treatment of this disease, an innovative prolonged release formulation of mebeverine has been introduced: the micro-granular 200 mg capsule. It means mebeverine is released slowly over the day to give an even effect.
Irritable Bowel Syndrome (IBS)
Statistically one out of 10 people suffers from IBS. It is one of the most common conditions seen by gastroenterologists. Almost any person of any age may be vulnerable to IBS, including children who often have some other symptoms. IBS is seen twice as often in women, than it is in men. Only a small group of sufferers consults a physician.
Symptoms that may be present in patients with IBS are abdominal pain, diarrhea, constipation, abdominal distension or flatulence, rectal mucus, sensation of incomplete evacuation. Other symptoms are heartburn, dyspepsia, nausea, early satiety and excessive belching.
Visit our website http://www.solvay-ibs.com for more information on IBS.
|
|
|
|
|
|
